Thomas J. Anchordoquy

6.7k total citations · 2 hit papers
86 papers, 5.4k citations indexed

About

Thomas J. Anchordoquy is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Thomas J. Anchordoquy has authored 86 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 17 papers in Immunology and 16 papers in Biomaterials. Recurrent topics in Thomas J. Anchordoquy's work include RNA Interference and Gene Delivery (53 papers), Protein purification and stability (16 papers) and Nanoparticle-Based Drug Delivery (14 papers). Thomas J. Anchordoquy is often cited by papers focused on RNA Interference and Gene Delivery (53 papers), Protein purification and stability (16 papers) and Nanoparticle-Based Drug Delivery (14 papers). Thomas J. Anchordoquy collaborates with scholars based in United States, Netherlands and Italy. Thomas J. Anchordoquy's co-authors include Michael W. Graner, Tyson Smyth, J. Verhoef, Peter Smith‐Jones, Long Xu, Max Kullberg, Marion d.C. Molina, Steven Allison, Jasmina S. Redzic and John F. Carpenter and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.

In The Last Decade

Thomas J. Anchordoquy

85 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes

2014 600 citations Tyson Smyth, Max Kullberg et al. Journal of Controlled Release profile →
Addressing the Cold Reality of mRNA Vaccine Stability

2020 342 citations Daan J.A. Crommelin, Thomas J. Anchordoquy et al. Journal of Pharmaceutical Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas J. Anchordoquy United States	38	4.1k	1.1k	936	883	571	86	5.4k
Steve R. Roffler Taiwan	42	3.4k 0.8×	691 0.7×	1.1k 1.2×	905 1.0×	1.2k 2.1×	168	6.1k
Kenneth A. Howard Denmark	42	4.3k 1.1×	909 0.9×	1.6k 1.7×	1.5k 1.7×	520 0.9×	108	6.8k
James E. Dahlman United States	40	5.0k 1.2×	694 0.7×	1.4k 1.5×	1.5k 1.7×	795 1.4×	76	7.3k
Steven M. Ansell United States	24	3.7k 0.9×	387 0.4×	988 1.1×	559 0.6×	703 1.2×	47	4.9k
Arwyn T. Jones United Kingdom	41	4.6k 1.1×	423 0.4×	1.0k 1.1×	682 0.8×	569 1.0×	129	6.6k
Jessie L.‐S. Au United States	44	3.0k 0.7×	783 0.7×	1.6k 1.7×	1.2k 1.4×	322 0.6×	164	7.1k
Sherry Y. Wu United States	29	2.6k 0.6×	725 0.7×	1.1k 1.2×	829 0.9×	537 0.9×	66	4.4k
Zicai Liang China	45	3.8k 0.9×	1.2k 1.1×	948 1.0×	1.1k 1.2×	636 1.1×	125	5.7k
Roy van der Meel Netherlands	31	5.6k 1.4×	964 0.9×	1.8k 1.9×	1.9k 2.1×	1.1k 1.8×	51	7.9k
Yusuke Sato Japan	47	4.2k 1.0×	656 0.6×	932 1.0×	1.3k 1.5×	1.5k 2.6×	218	6.9k

Countries citing papers authored by Thomas J. Anchordoquy

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Anchordoquy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Anchordoquy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Anchordoquy more than expected).

Fields of papers citing papers by Thomas J. Anchordoquy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Anchordoquy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Anchordoquy. The network helps show where Thomas J. Anchordoquy may publish in the future.

Co-authorship network of co-authors of Thomas J. Anchordoquy

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Anchordoquy. A scholar is included among the top collaborators of Thomas J. Anchordoquy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Anchordoquy. Thomas J. Anchordoquy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crommelin, Daan J.A., Thomas J. Anchordoquy, David B. Volkin, Wim Jiskoot, & Enrico Mastrobattista. (2020). Addressing the Cold Reality of mRNA Vaccine Stability. Journal of Pharmaceutical Sciences. 110(3). 997–1001. 342 indexed citations breakdown →

Cook, Mark, Michael A. Murphy, Kristian Bulluss, et al.. (2020). Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: A first-in-man study. EClinicalMedicine. 22. 100326–100326. 37 indexed citations

Anchordoquy, Thomas J., Yechezkel Barenholz, Diana Boraschi, et al.. (2017). Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. ACS Nano. 11(1). 12–18. 256 indexed citations

Hellwinkel, Justin E., Helen J. Madsen, Tessa Harland, et al.. (2016). HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*. International Journal of Hyperthermia. 33(3). 303–317. 10 indexed citations

Smyth, Tyson, Max Kullberg, Noeen Malik, et al.. (2014). Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. Journal of Controlled Release. 199. 145–155. 600 indexed citations breakdown →

Smyth, Tyson, Jasmina S. Redzic, Michael W. Graner, & Thomas J. Anchordoquy. (2014). Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1838(11). 2954–2965. 168 indexed citations

Verhoef, J., John F. Carpenter, Thomas J. Anchordoquy, & Huub Schellekens. (2014). Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discovery Today. 19(12). 1945–1952. 213 indexed citations

Verhoef, J. & Thomas J. Anchordoquy. (2013). Questioning the use of PEGylation for drug delivery. Drug Delivery and Translational Research. 3(6). 499–503. 276 indexed citations

Xu, Long & Thomas J. Anchordoquy. (2010). CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics. Journal of Pharmaceutical Sciences. 100(1). 38–52. 163 indexed citations

10.

Anchordoquy, Thomas J., et al.. (2010). Conference Report: The International Conference on the Freeze-Drying of Pharmaceuticals and Biologicals. Therapeutic Delivery. 2(1). 15–17. 1 indexed citations

11.

Anchordoquy, Thomas J., et al.. (2007). Preservation of DNA. 5(4). 180–188. 78 indexed citations

12.

Anchordoquy, Thomas J., et al.. (2006). Rationale for the Selection of an Aerosol Delivery System for Gene Delivery. Journal of Aerosol Medicine. 19(3). 372–384. 36 indexed citations

13.

Molina, Marion d.C. & Thomas J. Anchordoquy. (2006). Metal contaminants promote degradation of lipid/DNA complexes during lyophilization. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(3). 669–677. 24 indexed citations

14.

Patel, Mayank M. & Thomas J. Anchordoquy. (2005). Contribution of Hydrophobicity to Thermodynamics of Ligand-DNA Binding and DNA Collapse. Biophysical Journal. 88(3). 2089–2103. 63 indexed citations

15.

Zhang, Ye & Thomas J. Anchordoquy. (2004). The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1663(1-2). 143–157. 105 indexed citations

16.

Armstrong, Taylor, et al.. (2002). Effects of PEGylation on the Preservation of Cationic Lipid/DNA Complexes during Freeze-Thawing and Lyophilization. Journal of Pharmaceutical Sciences. 91(12). 2549–2558. 22 indexed citations

17.

Molina, Marion d.C., Steven Allison, & Thomas J. Anchordoquy. (2001). Maintenance of Nonviral Vector Particle Size During the Freezing Step of the Lyophilization Process is Insufficient for Preservation of Activity: Insight From Other Structural Indicators. Journal of Pharmaceutical Sciences. 90(10). 1445–1455. 71 indexed citations

18.

Anchordoquy, Thomas J., et al.. (2001). Physical stabilization of DNA-based therapeutics. Drug Discovery Today. 6(9). 463–470. 41 indexed citations

19.

Anchordoquy, Thomas J. & Gary S. Koe. (2000). Physical stability of nonviral plasmid-based therapeutics. Journal of Pharmaceutical Sciences. 89(3). 289–289. 3 indexed citations

20.

Anchordoquy, Thomas J., John F. Carpenter, & David J. Kroll. (1997). Maintenance of Transfection Rates and Physical Characterization of Lipid/DNA Complexes after Freeze-Drying and Rehydration. Archives of Biochemistry and Biophysics. 348(1). 199–206. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact